References:
Abdul-Ridha A, Lopez L, Keov P, Thal DM, Mistry SN, PM (2014) Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor J. Biol. Chem. Chem. 289: 6068-6079.
Allen JA, Yost JM, Setola V, Chen X, Sassano MF, Chen M, Peterson S, Yadav PN, Huang XP, Feng B, et al. (2011) Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci USA 108: 18488-18493.
Arrowsmith J (2011) Trial watch: phase II failures: 2008–2010. Nat Rev Drug Discov 10:328–329
Audet N, Galés C, Archer-Lahlou E, Vallières M, Schiller PW, Bouvier M, and Pineyro G (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283: 15078–15088
.Aurelio L, Baltos J-A, Ford L, Nguyen ATN, Jörg M, Devine SM, Valant C, White PJ, Christopoulos A, May LT, et al. (2018) A structure-activity relationship study of bitopic N6-substituted adenosine derivatives as biased adenosine A1 receptor agonists. J Med Chem 61:2087–2103
Baltos JA, Vecchio EA, Harris MA, Qin CX, Ritchie RH, Christopoulos A, White PJ, and May LT (2017) Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism. Biochem Pharmacol 135:79–89
Baker JG, Hall IP, and Hill SJ (2003) Agonist and inverse agonist actions of beta blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol 64:1357–1369.
Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141–162
Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, and Caron MG (2003) Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23:10265–10273.
Bunnage ME, Piatnitski Chekler EL, Jones LH. (2013) Target validation using chemical probes Nature Chem Biol 9:195–199.
Cahill, T. J. III Thomsen ARB, Tarrasch JT, Plouffee B, Nguyen AH, Yangg F, et al (2017) Distinct conformations of GPCR–β-arrestin complexes mediate desensitization, signaling, and endocytosis. Proc. Natl. Acad. Sci. USA 114, 2562–2567(2017).
Cai B, El Daibani A, Bai Y, Che T, Krusemark CJ.(2023) Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells JACS 3(4):1076-1088. doi: 10.1021/jacsau.2c00674
Cao Y, van der Velden WJC, Namkung Y, Nivedha AK, Cho A, Sedki D, Holleran B, et al (2023) Unraveling allostery within the angiotensin II type 1 receptor for Gαq and β-arrestin coupling. Sci Signal. 16(797):
Che T, Dwivedi-Agnihotri H, Shukla AK, Roth BL. (2021) Biased ligands at opioid receptors: Current status and future directions Sci Signal. ; 14(677): doi:10.1126/scisignal.aav0320
Chen Q, Tesmer JJG. (2022) G protein-coupled receptor interactions with arrestins and GCR kinases: The unresolved issue of signal bias. J Biol. Chem. 298:102279.
Chen K, Zhang C, Lin S, Yan X, Cai H, Yi C. et al (2023) Tail engagement of arrestin at the glucagon receptor. Nature https://www.nature.com/articles/s41586-023-06420
Cho HP, Engers DW,Venable DF,Niswender CM, Lindsley CW, et al (2014) A Novel Class of Succinimide-Derived Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Provides Insight into a Disconnect in Activity between the Rat and Human Receptors ACS Chem. Neurosci. 5:597−610
Christmanson L, Westermark P, and Betsholtz C (1994) Islet amyloid polypeptide stimulates cyclic AMP accumulation via the porcine calcitonin receptor. Biochem Biophys Res Commun 205:1226–1235.
Conibear AE, Kelly E. (2019) A Biased View of µ-Opioid Receptors? Mol Pharmacol 96: 542-549
Conibear AE, Asghar J, Hill R, Henderson G, Borbely E, Tekus V, Helyes Z, Palandri J, Bailey C, Starke I, von Mentzer B, et al. (2020) A novel G protein-biased agonist at the δ opioid receptor with analgesic efficacy in models of chronic pain. J Pharmacol Exp Ther.; 372:224–236. [PubMed: 31594792
Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, et al (2014) Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework Nature Rev Drug Disc 13:419–431.
Darbalaei S, Yuliantie E, Dai A, Chang R, Zhao P, Yang D, et al (2020) Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors Biochem Pharmacol 180:114150.
Devost D, Sleno R, Pétrin D, Zhang A, Shinjo Y, Okde R, Aoki J, Inoue A, and Hébert TE (2017) Conformational profiling of the AT1 angiotensin II receptor reflects biased agonism, G protein coupling, and cellular context. J Biol Chem 292:5443–5456
Drube J, Haider RS, Matthees E, Reichel M, Zeiner J, Fritzwanker S, et al ( 2022) GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation Nature Commun 13:540
Duan J, Liu H, Zhao F, Yuan Q, Ji Y, Cai X, He X,et al (2023) GPCR activation and GRK2 assembly by a biased intracellular agonist. Nature. doi: 10.1038
Eason MG, Kurose H, Holt BD, Raymond JR, and Liggett SB (1992) Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J Biol Chem 267:15795–15801.
Eiger DS, Boldizsar N, Honeycutt CC, Gardner J, Kirchner S, Hicks C, et al (2022) Location bias contributes to functionally selective responses of biased CXCR3 agonists. Nature Commun 13: 5846.
El Daibani AE, Paggi JM, Kim K, Laloudakis YD, Popov P, Bernhard SM, et al (2023) Molecular mechanism of biased signaling at the kappa opioid receptor Nature Commun 14:1338
Erickson CE, Gul R, Blessing CP, Nguyen J, Liu T, Pulakat L, Bastepe M, Jackson EK, and Andresen BT (2013) The β-blocker nebivolol is a GRK/β-arrestin biased agonist. PLoS One 8:e71980.
Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen D, and Bouxsein ML (2005) Bone response to intermittent parathyroid hormone is altered in mice null for β-arrestin2. Endocrinology 146:1854–1862
Fletcher MM, Halls ML, Zhao P, Clydesdale L, Christopoulos A, Sexton, Wootten D. (2018) Glucagon-like peptide-1 receptor internalization controls spatiotemporal signalling mediated by biased agonists. Biochem Pharmacol. 156:406-419.
Gentry, P. R., Kokubo, M., Bridges, T. M., Kett, N. R., Harp, J. M., Cho, H. P., et al. (2013). Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4- chlorophenyl)-1-(3, 4 difluorobenzoyl)-2, 3-dihydro-1H-imidazo[2, 1-a] isoindol-5(9bH)-one (ML375). J. Med. Chem. 56, 9351–9355
Ghanouni P, Gryczynski Z, Steenhuis JJ, Lee TW, Farrens DL, Lakowicz JR, and Kobilka BK (2001) Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J Biol Chem 276:24433–24436.
Gregory KJ, Hall NE, Tobin AB, Sexton PM, Christopoulos A. (2010) Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias J Biol Chem 285:7459-7474.
Haider RS, Reichel M, Matthees ESF, Hoffmann C. (2023) Conformational flexibility of β-arrestins-How these scaffolding proteins guide and transform the functionality of GPCRs. BioEssays 45: 2300053.
Hellyer SD, Sengmany K, Keller AN, Christopoulos A, Leach K, Gregory KJ. (2020) Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site. Biochem Pharmacol. 2020 Jul;177:114013.
Jarpe MB, Knall C, Mitchell FM, Buhl AM, Duzic E, and Johnson GL (1998) [D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors. J Biol Chem 273:3097–3104.
Jiang Y, Yeasmin M, Gondin AB, Christopoulos A, Valant C, Burger WAC, et al, (2022) Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor. Br. J Pharmacol doi: 10.1111/bph.16021.
Johnson TA, Milan-Lobo L, Che T, Ferwerda M, Lambu E, McIntosh NL, Li F, He L, Lorig-Roach N, Crews P, et al. (2017) Identification of the first marine-derived opioid receptor “balanced” agonist with a signaling profile that resembles the endorphins. ACS Chem Neurosci 8:473–485.
Jones B. (2021) The therapeutic potential of GLP-1 receptor biased agonism Br J Pharmacol. 2022;179:492–510.
Jozwiak K, Toll L, Jimenez L, Woo AY-H, Xiao R-P, and Wainer IW (2010) The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor. Biochem Pharmacol 79:1610–1615
Kayser C, Melkes B, Derieux C, Bock A. (2023) Spatiotemporal GPCR signaling illuminated by genetically encoded fluorescent biosensors. Curr Opin Pharmacol. 71:102384.
Kenakin TP. (1984) The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br J Pharmacol. 81(1):131-41.
Kenakin T (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232–238.
Kenakin TP (2003) Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol Sci 24: 346-354.
Kenakin T (2005) New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat Rev Drug Discov 4:919–927.
Kenakin T (2017) A scale of agonism and allosteric modulation for assessment of selectivity, bias, and receptor mutation Mol Pharmacol 92:414–424.
Kenakin T. (2019) Biased Receptor Signaling in Drug Discovery Pharmacol Rev. 7:267-315
Kenakin, TP (2021) Biased agonism as allosteric probe dependence. Cell Signal. 79: 109844.
Kenakin TP and Morgan PH (1989) Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol Pharmacol 35:214–222.
Kenakin T, Onaran O. (2002) The ligand paradox between affinity and efficacy: can you be there and not make a difference? Trends Pharmacol Sci. 23:275-80. doi: 10.1016/s0165-6147(02)02036-9
Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, and Novick S (2012) A simple method for quantifying functional selectivity and agonist bias. ACS ChemNeurosci 3:193–203.
Kim IM, Tilley DG, Chen J, Salazar NC, Whalen EJ, Violin JD, and Rockman HA (2008) β-blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci USA 105:14555–14560.
Klein Herenbrink C, Sykes DA, Donthamsetti P, Canals M, Coudrat T, Shonberg J, Scammells PJ, Capuano B, Sexton PM, Charlton SJ, et al. (2016) The role of kinetic context in apparent biased agonism at GPCRs. Nat Commun 7:10842
Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, and Struthers RS (2004) Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor
Kolb P, Kenakin T, Alexander SPH, Bermudez M, Bohn LM, Breinholt CS, et al (2022) Community guidelines for GPCR ligand bias: IUPHAR review Br J Pharmacol.179:3651-3674.
Krumm BE, DiBerto JF, Olsen RHJ, Kang HJ, Slocum ST, Zhang S, et al (2023) Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator Biochem. 62: 1233-1248
Kudlacek O, Waldhoer M, Kassack MU, Nickel P, Salmi JI, Freissmuth M, and Nanoff C (2002) Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Go-alpha in human brain. Naunyn Schmiedebergs Arch Pharmacol 365:8–16.
Lambert D, Calo G. (2020) Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults Br. J Anaesthes. 10.106/j.bja.2020.09.021
Laschet C, Dupuis N, Hanson J, (2019) A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR–G protein interactions. J Biol. Chem. 294: 4079-4090
Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, and Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes Neuropsychopharmacology 20:612–627
Leandera M, Tuanb Y, Megera A, Cuib Q, Raman S. (2020) Functional plasticity and evolutionary adaptation of allosteric regulation. Proc Natl Acad Sci 117: 25445-25454
Le Rouzic V, Narayan A, Hunkle A, Marrone GF, Lu Z, Majumdar S, Xu J, Pan YX, and Pasternak GW (2019) Pharmacological characterization of levorphanol, a G-protein biased opioid analgesic. Anesth Analg 128:365–373
Li A, Samuel Liu S, Huang R, Ahn S, Lefkowitz RJ, (2023) Loss of biased signaling at a G protein-coupled receptor in overexpressed systems (2023) PLOS ONE | https://doi.org/10.1371 /journal.pone.0283477
Liu H, Ma H, Zeng X, Wu C, Acharya S, Sudan SK, et al (2023) Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases. Int J Mol Sci. 24(12):10031.
Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, et al (2023) Comparative study of the molecular mechanisms underlying the G protein and β-arrestin-dependent pathways that lead to ERKs activation upon stimulation by Dopamine D2 receptor. FEBS J.. doi: 10.1111/febs.16921.
Liu JJ, Horst R, Katritch V, Stevens RC, Wuthrich K et al (2012) Biased signaling pathways in α2-adrenergic receptor characterized by19F-NMR. Science 335: 1106-1110
Luscombe VB, Baena-Lopez L, Bataille CJR, Russell AJ, Greaves DR (2023) Kinetic insights into agonist-dependent signalling bias at the pro-inflammatory G-protein coupled receptor GPR84 Eur Pharmacol 0014-2999
Luttrell LM, Maudsley S, Gesty-Palmer D. (2018) Translating in vitro ligand bias to in vivo efficacy. Cell Signal. 41: 46-55.
Lutz JA, Sulima A, Gutman ES, Bow EW, Luo D, Kaska S, et al (2023) Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans. Molecules. 28:4795.
Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, et al. (1998) Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med 187:1215–1224.
Manning DR (2002) Measures of efficacy using G proteins as endpoints: differential engagement of G proteins through single receptors. Mol Pharmacol 62:451 452.
Mao L, Wei W, Chen J. (2023) Biased regulation of glucocorticoid receptors signaling. Biomed Pharmacother. 165:115145.
Matthees ES, Haider RS, Hoffmann C, Drube (2021) Differential Regulation of GPCRs—Are GRK Expression Levels the Key? Front. Cell Develop. Biol. 9: 687489.
Maudsley J, S, Martin B, Janssens MB, J, Etienne H, Jushaj A, van Gastela J, et al (2016) Informatic Deconvolution of Biased GPCR Signaling Mechanisms from in vivo Pharmacological Experimentation Methods. 1; 92: 51–63.
McDonald JK, van der Westhuizen E, Pham, V, Thompson G, Felder CC, Paul SM, (2022) Biased profile of xanomeline at the recombinant human m4 muscarinic acetylcholine receptor. ACS Chem Neurosci. 13:1206-1218
Mende F, Hundahl C, Plouffe B, Skova LJ, Sivertsena B, Madsena AN, et al (2018) Translating biased signaling in the ghrelin receptor system into differential in vivo functions Proc Natl Acad Sci USA 115: E10255-E10264
Morgan P, Van Der Graaf PH, Arrowsmith J, Feltner DE, Drummond KS, Wegner CD, Street SDA. (2012) Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival Drug Disc Today 17:419-424.
Morgan P, Brown DG, Lennard S, Anderton MJ, Barrett CJ, Eriksson U, et al (2018) Impact of a five-dimensional framework on R&D productivity at AstraZeneca Nature Rev Drug Disc 17: 167–181
Myslivecek J (2022) Multitargeting nature of muscarinic orthosteric agonists and antagonists. Front. Physiol. 13 https://doi.org/10.3389
Namkung Y, Legouill C, Kumar S, Cao Y, Teixeira A, Lukasheva V, et al (2018) Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors Sci Signal 11: 559.
Olsen RHJ, DiBerto JF, English JG, et al. (2020) TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat Chem Biol. 16:841-849
Onaran HO, Ambrosio C, Ugur Ö, Madaras Koncz E, Grò MC, Vezzi V, Rajagopal S, Costa T (2017) Systematic errors in detecting biased agonism: analysis of current methods and development of a new model-free approach. Sci Rep 7:44247
Park JC, Luebbers A, Dao M, Semeano A, Nguyen AM, Papakonstantinou MP, et al (2023) Fine-tuning GPCR-mediated neuromodulation by biasing signaling through different G protein subunits.Mol Cell. 83(14):2540-2558.e12
Pang PS, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz P, et al (2017) Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure; a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). Eur. Heart J. 38: 2364-2373.
Pedersen MF, Wróbel TM, Märcher-Rørsted E, Pedersen DS, Møller TC, Gabriele F, et al (2020) Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics Neuropharma 166: 107718
Peters MF and Scott CW (2009) Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J Biomol Screen 14:246–255
Pottie E, Poulie CBM, Simon IA, Harpsøe K, D’Andrea L, Komarov I, et al, (2023) Structure−Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5‑HT2A Receptor Agonists ACS Chem. Neurosci. 14: 2727−2742
Raehal KM, Walker JK, and Bohn LM (2005) Morphine side effects in β-arrestin 2 knockout mice. J Pharmacol Exp Ther 314:1195–1201
Raehal KM and Bohn LM (2011) The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics Neuropharmacology 60:58–65.
Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM, (2011) Quantifying ligand bias at seven-transmembrane receptors Mol Pharmacol 80:367-77.
Randakova A, Jakubic J (2021) Functionally selective and biased agonists for muscarinic receptor. Pharmacol Res. 169:105641
Roth BL and Chuang DM (1987) Multiple mechanisms of serotonergic signal transduction. Life Sci 41:1051–1064.
Sarma P, Carino CMC, Seetharama D, Pandey S, Dwivedi-Agnihotri H, Rui X, et al (2023) Molecular insights into intrinsic transducer-coupling bias in the CXCR4-CXCR7 system Nature Communications 14, Article number: 4808
Sengmany K, Hellyer SD, Christopoulos A, Lapinsky DJ, Leach K, Gregory KJ. (2020) Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism Biochem Pharmacol. 2020 Jul;177:11401
Shukla AK, Westfield GH, Xiao K, Reis RI, Huang L-Y, Tripathi-Shukla P, et al (2014) Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature 512, 218–222 (2014).
Singleton S, Baptista-Hon DT, Edelstein E, McCaughey KS, Camplisson E, Hales TG (2021) TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available µ-opioid receptor number. Br J Pharmacol 178: 1855-1868
Skerrit JH, MacDonald RL (1984) Benzodiazepine receptor ligand actions on responses, Benzodiazepines, CL218872, zoplicone. Eur. J Pharmacol. 101: 127.
Soave M, Kellam B, Woolard J, Briddon SJ, Hill SJ. (2020) NanoBit Complementation to Monitor Agonist-Induced Adenosine A1 Receptor Internalization SLAS Disc. 25: 186-194
Sonoda N, Imamura T, Yoshizaki T, Babendure JL, Lu JC, and Olefsky JM (2008) Beta-arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci USA 105:6614–6619.
Sugihara S, Burnett JC. (2017) BAST-AHF: Insights into biased AT1 ligands and heart failure: Beginning of the end or end of the beginning? Eur. Heart J. 38:2374-2376.
Suomivuori CM, Latorraca NR, Wingler LM, Eismann S, King MC, Kleinhenz ALW, et al (2020) Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor. Science. 2020 Feb 21;367(6480):881-887
Tschammer N, Bollinger S, Kenakin T, Gmeiner P (2011) Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D Receptor Mol Pharmacol 79:575–585
Urs NM and Caron MG (2014) The physiological relevance of functional selectivity in dopamine signalling. Int J Obes Suppl 4 (Suppl 1):S5–S8
van der Westhuizen ET, Choy KHC, Valant C, McKenzie-Nickson S, Bradley SJ, Tobin AB, et al (2021) Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias. Front Pharmacol. 11:606656.
Violin JD, Lefkowitz RJ. (2007) β-Arrestin-biased ligands at seven-transmembrane receptors Trends Pharmacol Sci 28: 416-422.
Violin JD, Dewire SM, Barnes WG, and Lefkowitz RJ (2006) G protein-coupled receptor kinase and beta-arrestin-mediated desensitization of the angiotensin II type1A receptor elucidated by diacylglycerol dynamics. J Biol Chem 281:36411–36419.
Violin JD, DeWire SM, Yamashita D, Rominger DH, Nguyen L, Schiller K, Whalen EJ, Gowen M, and Lark MW (2010) Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. Pharmacol Exp Ther 335:572–579.
Violin JD, Crombie AL, Soergel DG, and Lark MW (2014) Biased ligands at G-protein-coupled receptors: promise and progress. Trends Pharmacol Sci 35: 308–316.
Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N. APOLLO-1: (2019) A randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein biased ligand at the μ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy. J Pain Res. 2019; 12:927–943. [PubMed: 30881102]
Vuckovic Z, Wang J, Pham V, Mobbs JI, Belousoff MJ, Bhattarai A, et al (2023) Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics eLife 2023;12:e83477
Wang S, Peng L, Kim KM. (2023) Biased Dopamine D2 Receptors Exhibit Distinct Intracellular Trafficking Properties and ERK Activation in Different Subcellular Domains. Biomol Ther doi: 10.4062
Watson C, Chen G, Irving P, Way J, Chen WJ, and Kenakin T (2000) The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. Mol Pharmacol 58: 1230–1238
Whistler JL and von Zastrow M (1999) Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. J Biol Chem 274:24575–24578.
White KL, Scopton AP, Rives ML, Bikbulatov RV, Polepally PR, Brown PJ, Kenakin T, Javitch JA, Zjawiony JK, and Roth BL (2014) Identification of novel functionally selective κ-opioid receptor scaffolds. Mol Pharmacol 85:83–90
Willard FS, Douros J D, Gabe MB, Showalter AD, Wainscott DB,Suter TM.et al (2020) Tirzepatide is an imbalanced and biased dual GIP and GLP-1receptor agonist. JCI Insight, 5, e140532. https://doi.org/10.1172/jci
Wingler LM, Elgeti M, Hilger D, Latorraca NR, Lerch MT, Staus DP, et al (2019) Angiotensin Analogs with Divergent Bias Stabilize Distinct Receptor Conformations Cell. 176(3):468-478.e11.
Wingler LM, Skiba MA, McMahon C, Staus DP, Kleinhenz ALW, Suomivuori CM, et al (2020) Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR Science. 367(6480):888-892
Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK, and Lefkowitz RJ (2007) A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling. Proc Natl Acad Sci USA 104:16657–16662
Yuliantie E, Darbalaei S, Dai A, Zhao P, Yang D, Sexton PM et al (2020) Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors Biochem. Pharmacol.177:114001
Zhao LH, He Q, Yuan Q, Gu Y, He X, Shan H, et al (2023) Conserved class B GPCR activation by a biased intracellular agonist. Nature. doi: 10.1038/s41586-023-0646
Zidar DA, Violin JD, Whalen EJ, Lefkowitz RJ. (2009). Selective engagement of G protein receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc. Natl. Acad. Sci USA 106:9649-9654.
.